I agree completely that this presentation gave compelling reasons for new investors to seriously consider Biocurex. However, why wasn't there a concurrent update for existing investors.

From Agoracom alone it is apparent that the crowd who have been faithfully following Biocurex is desperate for a corporate update.

I just don't get it. We shouldn't be finding this out from outside investors; it should be coming directly from the board to us.

I hope they continue getting the word out, BUT PLEASE KEEP US IN THE LOOP AT THE SAME TIME!!!